Cargando…

Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up

Erectile dysfunction significantly affects quality of life in young men. Authors have evaluated erectile function in men with coronary artery disease (CAD) and the relationship between the degree of erectile dysfunction (ED) and the age of their first acute myocardial infarction (AMI). The incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Dostálová, Gabriela, Hlubocká, Zuzana, Bayerová, Kristýna, Bělohlávek, Jan, Linhart, Aleš, Karetová, Debora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675271/
https://www.ncbi.nlm.nih.gov/pubmed/28697641
http://dx.doi.org/10.1177/1557988317714359
_version_ 1783276904605810688
author Dostálová, Gabriela
Hlubocká, Zuzana
Bayerová, Kristýna
Bělohlávek, Jan
Linhart, Aleš
Karetová, Debora
author_facet Dostálová, Gabriela
Hlubocká, Zuzana
Bayerová, Kristýna
Bělohlávek, Jan
Linhart, Aleš
Karetová, Debora
author_sort Dostálová, Gabriela
collection PubMed
description Erectile dysfunction significantly affects quality of life in young men. Authors have evaluated erectile function in men with coronary artery disease (CAD) and the relationship between the degree of erectile dysfunction (ED) and the age of their first acute myocardial infarction (AMI). The incidence of erectile dysfunction in three groups of patients of AMI survivors was investigated: AMI survivors younger than 45 years, AMI survivors older than 65 years, and normal male population aged between 30 and 60 years. Erectile function was assessed by the International Index of Erectile Function (IIEF-5) questionnaire. In post-AMI male patients younger than 45 years (n = 76), mild ED occurred in 26% and severe in 7%. In the older AMI group, mild ED occurred in 52% and severe in 38%. In the control group age matched to younger survivors, 96% denied ED and only one control patient had a score of 20 on the IIEF-5. A paradoxical result was observed in patients using beta blockers (BB), who had better scores than the group without BB. Statin treatment had a positive influence on the score in questionnaires. Those on statins had an average score of 21.0 ± 4.9 vs. without statin 17.7 ± 5.7, p = .03. The current findings identified that the prevalence of ED is relatively high in young patients with CAD and is related to treatment of the CAD. The overall increase in ED presence suggests that the background of their coronary event is not due to destabilization of single focused atheroma but may reflect a generalized atherosclerotic process.
format Online
Article
Text
id pubmed-5675271
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-56752712017-12-12 Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up Dostálová, Gabriela Hlubocká, Zuzana Bayerová, Kristýna Bělohlávek, Jan Linhart, Aleš Karetová, Debora Am J Mens Health Articles Erectile dysfunction significantly affects quality of life in young men. Authors have evaluated erectile function in men with coronary artery disease (CAD) and the relationship between the degree of erectile dysfunction (ED) and the age of their first acute myocardial infarction (AMI). The incidence of erectile dysfunction in three groups of patients of AMI survivors was investigated: AMI survivors younger than 45 years, AMI survivors older than 65 years, and normal male population aged between 30 and 60 years. Erectile function was assessed by the International Index of Erectile Function (IIEF-5) questionnaire. In post-AMI male patients younger than 45 years (n = 76), mild ED occurred in 26% and severe in 7%. In the older AMI group, mild ED occurred in 52% and severe in 38%. In the control group age matched to younger survivors, 96% denied ED and only one control patient had a score of 20 on the IIEF-5. A paradoxical result was observed in patients using beta blockers (BB), who had better scores than the group without BB. Statin treatment had a positive influence on the score in questionnaires. Those on statins had an average score of 21.0 ± 4.9 vs. without statin 17.7 ± 5.7, p = .03. The current findings identified that the prevalence of ED is relatively high in young patients with CAD and is related to treatment of the CAD. The overall increase in ED presence suggests that the background of their coronary event is not due to destabilization of single focused atheroma but may reflect a generalized atherosclerotic process. SAGE Publications 2017-07-11 2017-11 /pmc/articles/PMC5675271/ /pubmed/28697641 http://dx.doi.org/10.1177/1557988317714359 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Articles
Dostálová, Gabriela
Hlubocká, Zuzana
Bayerová, Kristýna
Bělohlávek, Jan
Linhart, Aleš
Karetová, Debora
Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
title Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
title_full Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
title_fullStr Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
title_full_unstemmed Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
title_short Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up
title_sort erectile dysfunction in young myocardial infarction survivors: evaluation, follow up
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675271/
https://www.ncbi.nlm.nih.gov/pubmed/28697641
http://dx.doi.org/10.1177/1557988317714359
work_keys_str_mv AT dostalovagabriela erectiledysfunctioninyoungmyocardialinfarctionsurvivorsevaluationfollowup
AT hlubockazuzana erectiledysfunctioninyoungmyocardialinfarctionsurvivorsevaluationfollowup
AT bayerovakristyna erectiledysfunctioninyoungmyocardialinfarctionsurvivorsevaluationfollowup
AT belohlavekjan erectiledysfunctioninyoungmyocardialinfarctionsurvivorsevaluationfollowup
AT linhartales erectiledysfunctioninyoungmyocardialinfarctionsurvivorsevaluationfollowup
AT karetovadebora erectiledysfunctioninyoungmyocardialinfarctionsurvivorsevaluationfollowup